Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia
NCT02868645Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- May 2016
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Periostin rate in serum. Started May 2016; status: completed.
Beyond the preview
Go deeper on NCT02868645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02868645.